Gergen Mark J
Insider CIK 1373110 · HALO SVP, Chief Operating Officer · MRTX Executive VP, COO · PSTX President and CEO, Director · AMLN SVP, Corporate Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 342,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 75,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 364,060 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 518,500 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 48,115 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 172,600 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 240,721 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 636,726 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2025-01-02 | 2025-01-03 | 23,313 | $9.60 | $223.8K | 630,726 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2024-12-10 | 2024-12-11 | 30,000 | — | $0 | 96,372 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-11 | 30,000 | $9.46 | $283.8K | 651,291 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2024-12-10 | 2024-12-11 | 30,000 | $2.78 | $83.4K | 681,291 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2024-11-26 | 2024-11-27 | 30,000 | — | $0 | 126,372 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2024-11-26 | 2024-11-27 | 30,000 | $2.78 | $83.4K | 681,291 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2024-11-26 | 2024-11-27 | 30,000 | $9.27 | $278.1K | 651,291 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 34,157 | $4.13 | $141.1K | 651,291 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2024-02-01 | 2024-02-02 | 47,162 | $3.41 | $160.8K | 685,448 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 172,600 | — | $0 | 172,600 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-01-02 | 2024-01-04 | 125,000 | — | $0 | 732,610 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-02 | 364,060 | — | $0 | 364,060 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-02 | 269,586 | — | $0 | 601,610 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2023-02-01 | 2023-02-03 | 31,819 | $7.00 | $222.7K | 330,314 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-01 | 518,500 | — | $0 | 518,500 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-01 | 357,200 | — | $0 | 357,200 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 342,000 | — | $0 | 342,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 45,568 | — | $0 | 45,568 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 72,925 | — | $0 | 72,925 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-09-01 | 2016-09-02 | 333,890 | — | $0 | 333,890 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-01-22 | 2016-01-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2016-01-15 | 2016-01-19 | 5,000 | — | $0 | 127,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2016-01-15 | 2016-01-19 | 10,000 | $25.92 | $259.2K | 117,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2016-01-15 | 2016-01-19 | 10,000 | $25.92 | $259.2K | 5,748 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2016-01-15 | 2016-01-19 | 10,000 | $8.50 | $85.0K | 15,748 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2016-01-15 | 2016-01-19 | 5,000 | $8.50 | $42.5K | 5,748 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2015-02-04 | 2015-02-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2013-07-17 | 2013-07-18 | 132,000 | — | $0 | 132,000 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 2,711 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 4,020 | $31.00 | $124.6K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 6,748 | $31.00 | $209.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 23,064 | $31.00 | $715.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 2,956 | $31.00 | $91.6K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 8,379 | $31.00 | $259.7K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 7,533 | $31.00 | $233.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 3,439 | $31.00 | $106.6K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 2,585 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 25,000 | $31.00 | $775.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 32,415 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 57,289 | $31.00 | $1.78M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 65,980 | $31.00 | $2.05M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 63,252 | $31.00 | $1.96M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 51,561 | $31.00 | $1.60M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 62,467 | $31.00 | $1.94M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 91,621 | $31.00 | $2.84M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 344 | $31.00 | $10.7K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 53,181 | $31.00 | $1.65M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 53,181 | $31.00 | $1.65M | 53,181 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | U Tender | 2012-08-08 | 2012-08-10 | 412 | $31.00 | $12.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | U Tender | 2012-08-08 | 2012-08-10 | 64,338 | $31.00 | $1.99M | 412 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | U Tender | 2012-08-08 | 2012-08-10 | 473 | $31.00 | $14.7K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | U Tender | 2012-08-08 | 2012-08-10 | 6,614 | $31.00 | $205.0K | 1,360 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | U Tender | 2012-08-08 | 2012-08-10 | 1,360 | $31.00 | $42.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | U Tender | 2012-08-08 | 2012-08-10 | 2,136 | $31.00 | $66.2K | 473 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-07-25 | 2012-07-26 | 936 | $14.62 | $13.7K | 64,750 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 8,379 | — | $0 | 8,379 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 91,621 | — | $0 | 91,621 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 10,000 | — | $0 | 63,814 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 1,529 | — | $0 | 7,974 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-03-01 | 2012-03-02 | 1,846 | $17.11 | $31.6K | 53,814 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-02-23 | 2012-02-24 | 7,518 | $17.03 | $128.0K | 54,826 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-22 | 2012-02-24 | 20,000 | — | $0 | 62,344 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-08 | 2012-02-10 | 8,000 | — | $0 | 45,477 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | F Tax w/h | 2012-02-08 | 2012-02-10 | 3,133 | $16.47 | $51.6K | 42,344 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-01-10 | 2012-01-12 | 15,000 | — | $0 | 37,477 | SEC↗ |